NCT02462239View on ClinicalTrials.gov

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging

NACompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

May 6, 2016

Primary Completion Date

March 31, 2024

Study Completion Date

November 14, 2024

Conditions
Muscle-invasive Bladder Cancer
Interventions
OTHER

Whole-body FDG PET-CT

Trial Locations (6)

L8V 5C2

Juravinski Cancer Centre, Hamilton

N6A 4L6

London Regional Cancer Centre, London

K1H 8L6

Ottawa Hospital Regional Cancer Centre, Ottawa

P7B 6V4

Thunder Bay Regional Health Sciences Centre, Thunder Bay

M4N 3M5

Sunnybrook Odette Cancer Centre, Toronto

M5G 2M9

Princess Margaret Cancer Centre, Toronto

Sponsors

Collaborators (1)

Cancer Care Ontario
All Listed Sponsors
collaborator

Cancer Care Ontario

OTHER

lead

Ontario Clinical Oncology Group (OCOG)

OTHER